Food and Drug Administration - Appendix A: Prevention


Goal To reduce transfusion-transmitted HIV infection.
Objective

Ensure supply and safety of the national blood supply.

Action Steps
  1. Establish policies
  2. Expedite review of product applications
  3. Conduct approval inspections
  4. Oversee surveillance
  5. Support enforcement activities
Descriptions

Encourage high risk donors to exclude themselves; update list of unsuitable donors; quarantine and test blood; investigate incidents to identify, and rectify common errors in blood banks.

Resources
FY95
FY96
FY96
$ 17.5 million
$ 17.5 million
$ 17.5 million
Populations
Served

All persons who may receive blood or blood products.

Constituency
Involvement

The FDA depends on scientific advisory committees to provide independent expert advice to the agency in its evaluation of regulated products. These committees are composed of representatives from academia, research, government, industry, and patient advocates.

 



Appendix A: Prevention

CDCC #1- Appendix A: Prevention

AHCPR

DoD

DoE

HUD

DoJ

VA

OPA

CNS

SAMHSA

HRSA

HCFA

IHS

NIH

FDA


President and First Lady | Vice President and Mrs. Gore
Record of Progress | The Briefing Room
Gateway to Government | Contacting the White House | White House for Kids
White House History | White House Tours | Help
Privacy Statement

Help

Site Map

Graphic Version

T H E   W H I T E   H O U S E